HeartBeam, Inc. (BEAT)

Market Cap	65.87M
Revenue (ttm)	n/a
Net Income (ttm)	-18.42M
Shares Out	26.56M
EPS (ttm)	-0.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,153
Open	2.520
Previous Close	2.500
Day's Range	2.410 - 2.598
52-Week Range	1.060 - 3.389
Beta	-0.99
Analysts	Buy
Price Target	8.00 (+222.58%)
Earnings Date	Nov 7, 2024

About BEAT

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Nov 11, 2021
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: BEAT
• Website: https://www.heartbeam.com

Analyst Forecast

According to one analyst, the rating for BEAT stock is "Buy" and the 12-month stock price forecast is $8.0.

Price Target

$8.0

(222.58% upside)

Analyst Consensus: Buy